Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Cognitive Impairment is Associated with Mortality in Hemodialysis Patients.

Angermann S, Schier J, Baumann M, Steubl D, Hauser C, Lorenz G, Günthner R, Braunisch MC, Kemmner S, Satanovskij R, Haller B, Heemann U, Lehnert T, Bieber R, Pachmann M, Braun J, Scherf J, Schätzle G, Fischereder M, Grimmer T, Schmaderer C.

J Alzheimers Dis. 2018;66(4):1529-1537. doi: 10.3233/JAD-180767.

PMID:
30412499
2.

Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.

Sagmeister MS, Weiss M, Eichhorn P, Habicht A, Habersetzer R, Fischereder M, Schönermarck U.

BMC Nephrol. 2018 Oct 19;19(1):270. doi: 10.1186/s12882-018-1086-z.

3.

Non-cardiac comorbidities in adults with inherited and congenital heart disease: report from a single center experience of more than 800 consecutive patients.

Neidenbach RC, Lummert E, Vigl M, Zachoval R, Fischereder M, Engelhardt A, Pujol C, Oberhoffer R, Nagdyman N, Ewert P, Hauser M, Kaemmerer H.

Cardiovasc Diagn Ther. 2018 Aug;8(4):423-431. doi: 10.21037/cdt.2018.03.11.

4.

Sarcopenia - Endocrinological and Neurological Aspects.

Stangl MK, Böcker W, Chubanov V, Ferrari U, Fischereder M, Gudermann T, Hesse E, Meinke P, Reincke M, Reisch N, Saller MM, Seissler J, Schmidmaier R, Schoser B, Then C, Thorand B, Drey M.

Exp Clin Endocrinol Diabetes. 2019 Jan;127(1):8-22. doi: 10.1055/a-0672-1007. Epub 2018 Sep 10. Review.

PMID:
30199918
5.

Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.

Bissler JJ, Nonomura N, Budde K, Zonnenberg BA, Fischereder M, Voi M, Louveau AL, Herbst F, Bebin EM, Curatolo P, Zonta A, Belousova E.

PLoS One. 2018 Sep 7;13(9):e0201005. doi: 10.1371/journal.pone.0201005. eCollection 2018.

6.

[Unexpected increase in serum-creatinine].

Fischereder M.

MMW Fortschr Med. 2018 Jul;160(13):36-38. doi: 10.1007/s15006-018-0767-7. Review. German. No abstract available.

PMID:
30014394
7.

Vascular rejection in renal transplant: Diagnostic value of contrast-enhanced ultrasound (CEUS) compared to biopsy.

Mueller-Peltzer K, Negrão de Figueiredo G, Fischereder M, Habicht A, Rübenthaler J, Clevert DA.

Clin Hemorheol Microcirc. 2018;69(1-2):77-82. doi: 10.3233/CH-189115.

PMID:
29630540
8.

Contrast-enhanced ultrasound (CEUS) as a new technique to characterize suspected renal transplant malignancies in renal transplant patients in comparison to standard imaging modalities.

Mueller-Peltzer K, Negrão de Figueiredo G, Fischereder M, Habicht A, Rübenthaler J, Clevert DA.

Clin Hemorheol Microcirc. 2018;69(1-2):69-75. doi: 10.3233/CH-189114.

PMID:
29630539
9.

Renal volume assessed by magnetic resonance imaging volumetry correlates with renal function in living kidney donors pre- and postdonation: a retrospective cohort study.

Lange D, Helck A, Rominger A, Crispin A, Meiser B, Werner J, Fischereder M, Stangl M, Habicht A.

Transpl Int. 2018 Jul;31(7):773-780. doi: 10.1111/tri.13150. Epub 2018 Apr 15.

10.

[Nephroprotection in patients with diabetes mellitus].

Fischereder M.

MMW Fortschr Med. 2017 Sep;159(15):60-62. doi: 10.1007/s15006-017-0012-9. Review. German. No abstract available.

PMID:
28924706
11.

The diagnostic value of contrast-enhanced ultrasound (CEUS) as a new technique for imaging of vascular complications in renal transplants compared to standard imaging modalities.

Mueller-Peltzer K, Rübenthaler J, Fischereder M, Habicht A, Reiser M, Clevert DA.

Clin Hemorheol Microcirc. 2017;67(3-4):407-413. doi: 10.3233/CH-179221.

PMID:
28885208
12.

Antibody response to HBV vaccination on dialysis does not correlate with the development of deNovo anti-HLA antibodies after renal transplantation.

Kauke T, Link M, Rentsch M, Stangl M, Guba M, Andrassy J, Werner J, Meiser B, Fischereder M, Habicht A.

Transpl Immunol. 2017 Jun;42:5-8. doi: 10.1016/j.trim.2017.04.003. Epub 2017 Apr 28.

PMID:
28457920
13.

Sodium storage in human tissues is mediated by glycosaminoglycan expression.

Fischereder M, Michalke B, Schmöckel E, Habicht A, Kunisch R, Pavelic I, Szabados B, Schönermarck U, Nelson PJ, Stangl M.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F319-F325. doi: 10.1152/ajprenal.00703.2016. Epub 2017 Apr 26.

14.

De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.

Kauke T, Oberhauser C, Lin V, Coenen M, Fischereder M, Dick A, Schoenermarck U, Guba M, Andrassy J, Werner J, Meiser B, Angele M, Stangl M, Habicht A.

Transpl Int. 2017 Apr;30(4):360-370. doi: 10.1111/tri.12887. Epub 2017 Feb 16.

15.

Exhaled breath volatile organic and inorganic compound composition in end-stage renal disease.

Schönermarck U, Dengler C, Gmeinwieser A, Praun S, Schelling G, Fischereder M, Boulesteix AL, Dolch ME.

Clin Nephrol. 2016 Sep;86(9):132-40. doi: 10.5414/CN108614.

PMID:
27443565
16.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Fischereder M, Schönermarck U.

N Engl J Med. 2016 Mar 17;374(11):1092-3. doi: 10.1056/NEJMc1600827. No abstract available.

PMID:
26981942
17.

Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.

Kauke T, Klimaschewski S, Schoenermarck U, Fischereder M, Dick A, Guba M, Stangl M, Werner J, Meiser B, Habicht A.

PLoS One. 2016 Jan 5;11(1):e0146075. doi: 10.1371/journal.pone.0146075. eCollection 2016.

18.

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.

Schnitzler F, Friedrich M, Stallhofer J, Schönermarck U, Fischereder M, Habicht A, Karbalai N, Wolf C, Angelberger M, Olszak T, Beigel F, Tillack C, Göke B, Zachoval R, Denk G, Guba M, Rust C, Grüner N, Brand S.

PLoS One. 2015 Aug 19;10(8):e0135807. doi: 10.1371/journal.pone.0135807. eCollection 2015.

19.

SDF-1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy.

Thomas MN, Kalnins A, Andrassy M, Wagner A, Klussmann S, Rentsch M, Habicht A, Pratschke S, Stangl M, Bazhin AV, Meiser B, Fischereder M, Werner J, Guba M, Andrassy J.

Transpl Int. 2015 Dec;28(12):1426-35. doi: 10.1111/tri.12651. Epub 2015 Sep 1.

20.

Spiegelmer Inhibition of MCP-1/CCR2--Potential as an Adjunct Immunosuppressive Therapy in Transplantation.

Kalnins A, Thomas MN, Andrassy M, Müller S, Wagner A, Pratschke S, Rentsch M, Klussmann S, Kauke T, Angele MK, Bazhin AV, Fischereder M, Werner J, Guba M, Andrassy J.

Scand J Immunol. 2015 Aug;82(2):102-9. doi: 10.1111/sji.12310.

21.

Membrane and centrifugal therapeutic plasma exchange: practical difficulties in anticoagulating the extracorporeal circuit.

Seibt T, Fischereder M, Schönermarck U.

Clin Kidney J. 2014 Aug;7(4):430. doi: 10.1093/ckj/sfu063. Epub 2014 Jul 8. No abstract available.

22.

Use of oestrogen-containing medication is not associated with renal angiomyolipoma in tuberous sclerosis: findings from a survey.

Sauter M, Sigl J, Schotten KJ, Kreuzer L, Günthner-Biller M, Fischereder M.

Int Urol Nephrol. 2015 Apr;47(4):707-8. doi: 10.1007/s11255-015-0936-x. Epub 2015 Mar 4. No abstract available.

PMID:
25737072
23.

[Nephrotic syndrome in a woman with tuberous sclerosis].

Sauter M, Berger F, Fischereder M.

Dtsch Med Wochenschr. 2014 May;139(20):1046-50. doi: 10.1055/s-0034-1370024. Epub 2014 May 6. German.

PMID:
24801299
24.

Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database.

Naik MG, Heller KM, Arns W, Budde K, Diekmann F, Eitner F, Fischereder M, Goßmann J, Heyne N, Morath C, Riester U, Gwinner W, Jürgensen JS; German Sirolimus Study Group.

Clin Transplant. 2014 Jan;28(1):67-79. doi: 10.1111/ctr.12280. Epub 2013 Dec 26.

PMID:
24372584
25.

Association of oestrogen-containing contraceptives with pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex--findings from a survey.

Sauter M, Sigl J, Schotten KJ, Günthner-Biller M, Knabl J, Fischereder M.

Eur J Contracept Reprod Health Care. 2014 Feb;19(1):39-44. doi: 10.3109/13625187.2013.859667. Epub 2013 Dec 10.

PMID:
24325602
26.

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.

Stoelben S, Arns W, Renders L, Hummel J, Mühlfeld A, Stangl M, Fischereder M, Gwinner W, Suwelack B, Witzke O, Dürr M, Beelen DW, Michel D, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Budde K.

Transpl Int. 2014 Jan;27(1):77-86. doi: 10.1111/tri.12225. Erratum in: Transpl Int. 2014 Apr;27(4):416.

27.

Headaches after renal transplantation--a case report.

Rau S, von Baumgarten L, Habicht A, Fischereder M, Schönermarck U.

Transplant Proc. 2013 Sep;45(7):2795-7. doi: 10.1016/j.transproceed.2013.03.051.

PMID:
24034052
28.

Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets.

Bielohuby M, Sisley S, Sandoval D, Herbach N, Zengin A, Fischereder M, Menhofer D, Stoehr BJ, Stemmer K, Wanke R, Tschöp MH, Seeley RJ, Bidlingmaier M.

Am J Physiol Endocrinol Metab. 2013 Nov 1;305(9):E1059-70. doi: 10.1152/ajpendo.00208.2013. Epub 2013 Aug 27.

29.

Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!

Rau S, Habicht A, Kauke T, Hillmer A, Wessely M, Stangl M, Guba M, Fischereder M, Schönermarck U.

Eur J Clin Invest. 2013 Aug;43(8):816-20. doi: 10.1111/eci.12110. Epub 2013 May 25.

PMID:
23710757
30.

CT perfusion technique for assessment of early kidney allograft dysfunction: preliminary results.

Helck A, Wessely M, Notohamiprodjo M, Schönermarck U, Klotz E, Fischereder M, Schön F, Nikolaou K, Clevert DA, Reiser M, Becker C.

Eur Radiol. 2013 Sep;23(9):2475-81. doi: 10.1007/s00330-013-2862-6. Epub 2013 May 10.

PMID:
23660773
31.

Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition.

Hartmann B, He X, Keller F, Fischereder M, Guba M, Schmid H.

Ther Drug Monit. 2013 Apr;35(2):233-9. doi: 10.1097/FTD.0b013e3182804c9b.

PMID:
23503450
32.

BK virus-associated nephropathy: neutrophil gelatinase-associated lipocalin as a new diagnostic tool?

Rau S, Schönermarck U, Jäger G, Stangl M, Guba M, Meiser B, Fischereder M, Habicht A.

Clin Transplant. 2013 Mar-Apr;27(2):E184-91. doi: 10.1111/ctr.12081. Epub 2013 Feb 13.

PMID:
23406465
33.

[45-year-old patient with facial swelling].

Rau S, Schönermarck U, Fischereder M.

Dtsch Med Wochenschr. 2013 Feb;138(6):267-8. doi: 10.1055/s-0032-1327403. Epub 2013 Jan 29. German. No abstract available.

PMID:
23361350
34.

[Nephron-sparing treatments for kidney cancer].

Casuscelli J, Fischereder M, Gratzke C, Staehler M, Stief CG.

MMW Fortschr Med. 2012 Dec 17;154(22):45-6, 48. German. No abstract available.

PMID:
23297539
35.

Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis.

Andrassy J, Hoffmann VS, Rentsch M, Stangl M, Habicht A, Meiser B, Fischereder M, Jauch KW, Guba M.

Transplantation. 2012 Dec 27;94(12):1208-17. doi: 10.1097/TP.0b013e3182708e56. Review.

PMID:
23269449
36.

Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients.

Pulzer A, Seybold U, Schönermarck U, Stangl M, Habicht A, Bogner JR, Franke J, Fischereder M.

Transpl Int. 2013 Mar;26(3):254-8. doi: 10.1111/tri.12020. Epub 2012 Dec 10.

37.

Cutaneous vasculitis after renal transplantation: a case report.

Rau S, Wollenberg A, Weiss M, Fischereder M, Schönermarck U.

Transplant Proc. 2012 Dec;44(10):3048-50. doi: 10.1016/j.transproceed.2012.04.037. Epub 2012 Sep 15. Review.

PMID:
23195025
38.

Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis.

Staehler M, Sauter M, Helck A, Linsenmaier U, Weber L, Mayer K, Fischereder M.

Int Urol Nephrol. 2012 Dec;44(6):1657-61. doi: 10.1007/s11255-012-0292-z. Epub 2012 Sep 28.

PMID:
23054313
39.

Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.

Steubl D, Baumann M, Schuster T, Fischereder M, Krämer BK, Heemann U, Lutz J.

Scand J Urol Nephrol. 2012 Dec;46(6):466-74. doi: 10.3109/00365599.2012.726643. Epub 2012 Sep 28.

PMID:
23016678
40.

How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al.

Schönermarck U, Rau S, Fischereder M.

Arthritis Rheum. 2012 Sep;64(9):3057-8; author reply 3058. doi: 10.1002/art.34590. No abstract available.

41.

Chronic kidney disease is not associated with a higher risk for mortality or acute kidney injury in transcatheter aortic valve implantation.

Wessely M, Rau S, Lange P, Kehl K, Renz V, Schönermarck U, Steinbeck G, Fischereder M, Boekstegers P.

Nephrol Dial Transplant. 2012 Sep;27(9):3502-8. doi: 10.1093/ndt/gfs102. Epub 2012 Apr 25.

PMID:
22535634
42.

Transcatheter aortic valve implantation in dialysis patients.

Rau S, Wessely M, Lange P, Kupatt C, Steinbeck G, Fischereder M, Schönermarck U.

Nephron Clin Pract. 2012;120(2):c86-90. doi: 10.1159/000335781. Epub 2012 Feb 22.

PMID:
22377618
43.

Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation.

Guba M, Pratschke J, Hugo C, Krämer BK, Pascher A, Pressmar K, Hakenberg O, Fischereder M, Brockmann J, Andrassy J, Banas B, Jauch KW; SMART-Study Group.

Transpl Int. 2012 Apr;25(4):416-23. doi: 10.1111/j.1432-2277.2012.01432.x. Epub 2012 Feb 10.

44.

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation.

Schönermarck U, Kauke T, Jäger G, Habicht A, Wendler T, Andrassy J, Guba M, Stangl M, Fischereder M.

J Transplant. 2011;2011:869065. doi: 10.1155/2011/869065. Epub 2011 Dec 8.

45.

Comparison of Gd-DTPA and Gd-BOPTA for studying renal perfusion and filtration.

Notohamiprodjo M, Pedersen M, Glaser C, Helck AD, Lodemann KP, Jespersen B, Fischereder M, Reiser MF, Sourbron SP.

J Magn Reson Imaging. 2011 Sep;34(3):595-607. doi: 10.1002/jmri.22640. Epub 2011 Jul 14.

PMID:
21761461
46.

Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.

Schönermarck U, Rau S, Fischereder M.

N Engl J Med. 2010 Nov 18;363(21):2072; author reply 2073-4. doi: 10.1056/NEJMc1009101. No abstract available.

PMID:
21083401
47.

Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients.

Eitner F, Hauser IA, Rettkowski O, Rath T, Lopau K, Pliquett RU, Fiedler R, Guba M, Hilgers RD, Floege J, Fischereder M.

Nephrol Dial Transplant. 2011 Jun;26(6):2013-7. doi: 10.1093/ndt/gfq689. Epub 2010 Nov 11.

PMID:
21071545
48.

A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort.

Krüger B, Banas MC, Walberer A, Böger CA, Farkas S, Hoffmann U, Fischereder M, Banas B, Krämer BK.

Clin Sci (Lond). 2010 Dec;119(12):535-44. doi: 10.1042/CS20100190.

PMID:
20604744
49.

[Another "suspect": homeopathic agent associated with acute interstitial nephritis].

Türkoglu-Raach G, Gröne HJ, Sitter T, Fischereder M.

Dtsch Med Wochenschr. 2010 Jun;135(24):1224-7. doi: 10.1055/s-0030-1255140. Epub 2010 Jun 8. German.

PMID:
20533155
50.

Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial.

Guba M, Pratschke J, Hugo C, Krämer BK, Nohr-Westphal C, Brockmann J, Andrassy J, Reinke P, Pressmar K, Hakenberg O, Fischereder M, Pascher A, Illner WD, Banas B, Jauch KW; SMART-Study Group.

Transplantation. 2010 Jul 27;90(2):175-83. doi: 10.1097/TP.0b013e3181e11798.

PMID:
20463641

Supplemental Content

Loading ...
Support Center